156 related articles for article (PubMed ID: 1453124)
1. Occurrence of species of low-density lipoprotein with defective clearance in patients with primary moderate hypercholesterolaemia.
Vega GL; Grundy SM
J Intern Med; 1992 Nov; 232(5):405-13. PubMed ID: 1453124
[TBL] [Abstract][Full Text] [Related]
2. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
[TBL] [Abstract][Full Text] [Related]
3. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
[TBL] [Abstract][Full Text] [Related]
6. Familial defective apolipoprotein B-100 (FDB): effect of simvastatin therapy on LDL-receptor binding.
Mamotte CD; Sturm M; Foo JI; van Bockxmeer FM; Taylor RR
Atherosclerosis; 1996 Aug; 125(1):103-10. PubMed ID: 8831932
[TBL] [Abstract][Full Text] [Related]
7. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK.
Wenham PR; Henderson BG; Penney MD; Ashby JP; Rae PW; Walker SW
Atherosclerosis; 1997 Mar; 129(2):185-92. PubMed ID: 9105560
[TBL] [Abstract][Full Text] [Related]
8. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM
J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944
[TBL] [Abstract][Full Text] [Related]
9. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
Morash B; Guernsey DL; Tan MH; Dempsey G; Nassar BA
Clin Biochem; 1994 Aug; 27(4):265-72. PubMed ID: 8001287
[TBL] [Abstract][Full Text] [Related]
10. Familial defective apo B-100, characterization of an Italian family.
Corsini A; McCarthy BJ; Granata A; Soria LF; Fantappiè S; Bernini ; Romano C; Romano L; Fumagalli R; Catapano AL
Eur J Clin Invest; 1991 Aug; 21(4):389-97. PubMed ID: 1936106
[TBL] [Abstract][Full Text] [Related]
11. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach.
Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M
J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585
[TBL] [Abstract][Full Text] [Related]
12. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
[TBL] [Abstract][Full Text] [Related]
13. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Miserez AR; Keller U
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
[TBL] [Abstract][Full Text] [Related]
14. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
Myant NB
Atherosclerosis; 1993 Dec; 104(1-2):1-18. PubMed ID: 8141833
[TBL] [Abstract][Full Text] [Related]
15. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
16. Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?
Maher VM; Gallagher JJ; Thompson GR; Myant NB
Atherosclerosis; 1995 Nov; 118(1):105-10. PubMed ID: 8579620
[TBL] [Abstract][Full Text] [Related]
17. Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100.
Corsini A; Mazzotti M; Villa A; Maggi FM; Bernini F; Romano L; Romano C; Fumagalli R; Catapano AL
Atherosclerosis; 1992 Mar; 93(1-2):95-103. PubMed ID: 1596308
[TBL] [Abstract][Full Text] [Related]
18. The binding of very low density lipoprotein remnants to the low density lipoprotein receptor in familial defective apolipoprotein B-100.
Maher VM; Gallagher JJ; Myant NB
Atherosclerosis; 1993 Aug; 102(1):51-61. PubMed ID: 8257452
[TBL] [Abstract][Full Text] [Related]
19. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
[TBL] [Abstract][Full Text] [Related]
20. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
Gaffney D; Forster L; Caslake MJ; Bedford D; Stewart JP; Stewart G; Wieringa G; Dominiczak M; Miller JP; Packard CJ
Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
